Inventor · disambiguated record
Markus Weigandt
Also filed as: WEIGANDT MARKUS
10 granted patents·6 pending applications·7 citations·filing 2009–2024
82Inventor score
Top patents by PatentIndex Score
16 records- 0182US9808521B2Silicon dioxide nanoparticles and the use thereof for vaccinationMERCK PATENT GMBH·Filed 2016·Granted Nov 7, 2017·3 cites·19 claims
- 0279US11058769B2Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody AvelumabMERCK PATENT GMBH·Filed 2016·Granted Jul 13, 2021·2 cites·40 claims
- 0372US11559490B2Pharmaceutical formulationMERCK PATENT GMBH·Filed 2018·Granted Jan 24, 2023·1 cites·27 claims
- 0470US2024408021A1Pharmaceutical formulationMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0567US8980324B2Silicon dioxide nanoparticles and the use thereof for vaccinationWEIGANDT MARKUS·Filed 2009·Granted Mar 17, 2015·1 cites·8 claims
- 0664US2023119567A1Pharmaceutical formulationMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 0762US10111952B2Silicon dioxide nanoparticles and the use thereof for vaccinationMERCK PATENT GMBH·Filed 2017·Granted Oct 30, 2018·0 cites·28 claims
- 0856US2021100903A1Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumabMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0953US9433673B2Silicon dioxide nanoparticles and the use thereof for vaccinationMERCK PATENT GMBH·Filed 2015·Granted Sep 6, 2016·0 cites·12 claims
- 1052US11478459B2Pharmaceutical preparationMERCK PATENT GMBH·Filed 2018·Granted Oct 25, 2022·0 cites·25 claims
- 1148US2023043290A1Igg:tgfbetarii fusion protein compositionARES TRADING SA·Filed 2020·Application pending·0 cites
- 1246US10561622B2Preparation of nanoparticles-releasing enteric microparticlesMERCK PATENT GMBH·Filed 2015·Granted Feb 18, 2020·0 cites·25 claims
- 1346US2022288068A1Pharmaceutical preparationMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1445US10561733B2Process for producing nanoparticles laden with active ingredientMERCK PATENT GMBH·Filed 2013·Granted Feb 18, 2020·0 cites·20 claims
- 1540US2016279213A1Survivin-Directed Cancer Vaccine TherapyMERCK PATENT GMBH·Filed 2014·Application pending·0 cites
- 1635US10369217B2Antigen-loaded chitosan nanoparticles for immunotherapyMERCK PATENT GMBH·Filed 2015·Granted Aug 6, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Markus Weigandt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →